{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:15:24Z","timestamp":1784330124474,"version":"3.55.0"},"reference-count":33,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2020,4,2]]},"DOI":"10.1080\/13696998.2019.1707209","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T07:05:45Z","timestamp":1576825545000},"page":"362-370","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["A cost-effectiveness and budget impact analysis of apremilast in patients with psoriasis in the Italian setting"],"prefix":"10.1080","volume":"23","author":[{"given":"Marco","family":"Barbieri","sequence":"first","affiliation":[{"name":"Centre for Health Economics, University of York, York, UK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Loconsole","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Bari, Bari, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Migliore","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, S. Pietro Fatebenefratelli Hospital, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Capri","sequence":"additional","affiliation":[{"name":"School of Economics and Management, Universit\u00e0 Cattaneo-LIUC, Castellanza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,1,20]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804595"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.339"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.12.018"},{"key":"CIT0004","volume-title":"Psoriasis: assessment and management of psoriasis","author":"National Clinical Guideline Centre (UK).","year":"2012"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.1034107"},{"key":"CIT0006","unstructured":"Otezla. Summary of Product Characteristics [Internet]. [cited 2019 May 8]. Available from: https:\/\/ec.europa.eu\/health\/documents\/community-register\/2015\/20150115130395\/anx_130395_en.pdf."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1080\/2331205X.2018.1495593"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.3310\/hta10460"},{"key":"CIT0009","unstructured":"National Clinical Guidelines Centre. Appendix P \u2013 Review of resource use and cost data to use in defining \u2018best supportive care\u2019 for NCGC economic model [Internet]. [cited 2019 May 8]. Available from: https:\/\/www.nice.org.uk\/guidance\/cg153\/evidence\/appendices-ju-pdf-188351538."},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15027"},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"Mughal F, Cawston H, Kinah D, et\u00a0al. Cost effectiveness of Apremilast in moderate to severe psoriasis in Scotland. ISPOR 18th Annual European Congress. 2015. Nov 7\u201311; MiCo - Milano Congressi, Milan, Italy.","DOI":"10.1016\/j.jval.2015.09.553"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.03.049"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08315.x"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60725-4"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030409"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.3310\/hta13suppl2\/07"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1159\/000113150"},{"key":"CIT0018","unstructured":"DETERMINAZIONE AIFA 3 luglio 2006. Elenco dei medicinali di classe a) rimborsabili dal Servizio sanitario nazionale (SSN) ai sensi dell\u2019articolo 48, comma 5, lettera c), del decreto-legge 30 settembre 2003, n. 269, convertito, con modificazioni, nella legge 24 novembre 2006, n. 326. (Prontuario farmaceutico nazionale 2006). (Gazzetta Ufficiale Serie Generale n.156 del 07-07-2006 - Suppl. Ordinario n. 161)"},{"key":"CIT0019","unstructured":"DETERMINAZIONE AIFA 27 settembre 2006. Manovra per il governo della spesa farmaceutica convenzionata e non convenzionata. (Gazzetta Ufficiale Serie Generale n.227 del 29-09-2006)"},{"key":"CIT0020","unstructured":"Ministero della Salute. Remunerazione delle prestazioni di assistenza ospedaliera per acuti, assistenza ospedaliera di riabilitazione e di lungodegenza post acuzie e di assistenza specialistica ambulatoriale. Gazzetta Ufficiale \u2013 Serie Generale n. 23 del 28-01-2013. Suppl. Ordinario n. 8."},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-014-0005-4"},{"issue":"2","key":"CIT0022","first-page":"91","volume":"10","author":"Associazione Italiana di Economia Sanitaria","year":"2009","journal-title":"Politiche Sanitarie"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02423.x"},{"key":"CIT0024","unstructured":"Istituto Nazionale di Statistica [Internet]. Available from: www.istat.it."},{"issue":"2","key":"CIT0025","first-page":"1","volume":"6","author":"Kheraoui F","year":"2017","journal-title":"QIJPH"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S168691"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211568"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14015"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14832"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.02.950"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2015.09.555"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2015.09.553"},{"issue":"7","key":"CIT0033","first-page":"848","volume":"13","author":"Levin AA","year":"2014","journal-title":"J Drugs Dermatol"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2019.1707209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T23:01:37Z","timestamp":1599260497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2019.1707209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,20]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,2]]}},"alternative-id":["10.1080\/13696998.2019.1707209"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2019.1707209","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-06-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}